PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine, Addenbrookes Hospital, University of Cambridge, Cambridge, UK.\', \'Department of Medicine, Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge, UK.\', \'Medical Research Council, Biostatistic Unit, Cambridge, UK.\', \'Department of Medicine, Cambridge Institute of Therapeutic Immunology and Infectious Disease, University of Cambridge, Cambridge, UK fm319@cam.ac.uk.\', \'Department of Medicine, Addenbrookes Hospital, University of Cambridge, Cambridge, UK ejdg2@cam.ac.uk.\']
?:citedBy
  • -1
?:creator
?:doi
  • e20210111610.26508/lsa.202101116
?:doi
?:hasPublicationType
?:journal
  • Life science alliance
is ?:pmid of
?:pmid
?:pmid
  • 35110354
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Topical TMPRSS2 inhibition prevents SARS-CoV-2 infection in differentiated human airway cultures.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/35110354>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/35110354>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all